![Matthew Greenhawt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Greenhawt
Corporate Officer/Principal bij Intrommune Therapeutics, Inc.
Actieve functies van Matthew Greenhawt
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Intrommune Therapeutics, Inc.
![]() Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Loopbaan van Matthew Greenhawt
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Corporate Officer/Principal | 1 |
Sectoraal
Miscellaneous | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Intrommune Therapeutics, Inc.
![]() Intrommune Therapeutics, Inc. MiscellaneousMiscellaneous Intrommune Therapeutics, Inc. operates as a biopharmaceutical company. The firm develops oral mucosal immunotherapy(OMIT) platform for food allergies. The company was founded by Michael Nelson and William Reisacher in 2015 and is headquartered in New York, NY. | Miscellaneous |
- Beurs
- Insiders
- Matthew Greenhawt
- Ervaring